- Business Development- Financing- Launch Readiness- Communication

Operations: - Participate and establish a comprehensive business plan and guarantee its execution. - Prioritise tasks to secure the critical path of the project - Optimise timelines and budgets to reach target milestones on time - Follow and prepare deliverables to be presented in board meetings - Managing resources and budgets - Representing the image and interests of the firm via communication and networking initiative- Analyse market trends, implications and proactively designing new strategiesBusiness:- Prepare corporate presentations and other communication supports.- Orchestrate the fund raising exercise- Establish and and execute the company’s business development strategy- Acte as the creative architect of the few complex deals to be signed by the company in the short term (strategic alliance; deals including equity investment; R&D collaborations…)

Contribute to the development of the Group drugs portfolio by actively looking for acquisition, licenses, products, or any other form of partnership, in the fields of metabolism (especially Diabetes) and Cardiology. - Strategy: Support strategy development initiatives to identify strategic business priorities; Definition of business development needs; Key contributor to the strategic assessments- Networking: Be the lead initial contact with external companies, including selling Servier capabilities ; Generate Licensing partnership opportunities by consistently developing and maintaining external (Scouting) and internal key networks;- Identify new products to add value to the Group;- Due Diligence: Pilot scientific, medical and economic evaluations of the projects, in close collaboration with internal and external experts, by conducting ad hoc working groups;- Negotiate the retained projects;

Therapeutic areas: Neurology, Endocrinology, Primary Care - Gastroenterology, Oncology, OTX/C- Seek, screen, evaluate and financial valuation of Companies, new products and/or technologies. Strategy: Structure the Business Development approach by the implementation validation processes - Definition of business development needs; Key contributor to the strategic assessments related to the long term vision and strategic planning exercise Networking: Representation of Ipsen, showcase Ipsen’s abilities to be a good partner. Participation to academic, partnering, investment meetings and conferences for networking, lead-generation, and continuing education purposes. Scouting for opportunities: Work closely with business leaders to understand and develop criteria for the identification and evaluation of opportunities. Due Diligence: Direct the operational aspects of Due Diligence projects (project management skills) - Guide / Influence the strategy by assessing the feasibility of projects and propose alternatives. Valuation: Evaluate opportunities through development of robust & compelling business cases in collaboration with cross-functional teams. Participate to the NPV and P&L valuation based on reliable and accurate information Negotiation: Leadership role in the negotiation process ; Accountable for negotiating high quality contracts and commitments to protect the commercial interests of the Company. Approval & Execution: Pilot the contracting phase and the top management (CEO / Board) presentations from negotiation to Execution.  Merger & Acquisition: M&A activity in Brazil, Russia and EU: Strategy, valuation and Due diligence for the acquisition and integration of Companies. Alliance management : Follow-up of the implementation of agreements, ensure smooth relationships with partners, solve potential issues, Deal record in licensing-out / out in EU, Brazil; lat-Am, Russia, Australia , Divestment of products, M&A

- Structure the Business Development approach in the region by the implementation of a validation process : Design and impose templates for internal validation of any BD opportunity.Define process, mandatory information and presentation format.Create an internal alliance management team and include the input from all relevant functions of the company into the Business Case.Make sure all business cases presented to senior management are compliant with the defined format.- Define region business development needs and search for opportunities :Participate in showcasing Ipsen’s abilities to be a good partner .Liaise with countries in order to obtain a short / medium term mapping of their needs. Consolidate mapping at region level to obtain a clear picture of local / region priority needs.Search for opportunities according to the mapping of priorities .For each opportunity, provide a brief for local evaluation including regulatory, medical, market research, & finance input. - Alliance management :Follow up the implementation of agreements: make sure Ipsen and partner adhere to their obligations, set up regular updates with countriesManage the alliance and manage changes in the alliances – ensure partnership and internal Ipsen alignment. Ensure smooth relationships with partners, solve potential issues.

Senior Regulatory product manager for Neurology (Dysport® (Botulinium toxin) and oncology (2 products under development)Intercontinental regulatory representative in charge of Neurology & Oncology franchise worldwide (except EU/US/Japan)Determination and Implementation of Regulatory strategy for the development purposes, in collaboration with the affiliate and/or partner. Integrated development plan for the oncology range including China & RussiaSubmission and follow-up on MA submission, variations, renewal, tender procedures in accordance with the regulation of the concerned country.Coordination and redaction of responses to question in collaboration with R&D teamsRegulatory intelligence and survey of international regulationsScreening, identification and participation to the choice of potential local partners, contracts review.Implementation of new tools to facilitate communication between corporate regulatory department and local regulatory.

Responsible for biotech products: Humalog® - Umuline® (Endocrinology) and Medical devices / Xigris® - Reopro® (Intensive Care),Variations and renewals , modification of the medical information (SmPC – leaflet – packaging),Control of promotional material ,Submission and Regulatory Follow-up on Clinical Trial (pilot phase),Regulatory follow-up on European regulation.

« Pharmaceutical Establishment » (French specificity – Inspection and Audit), VariationsCompliance Audit – Standard Operating Procedures, Import Licence, Regulatory Follow-up on Clinical Trial and Compassionate Use program Evaluation promotional material, Validation of SmPC – package Insert leaflet, Regulatory Project manager for Kineret®.

@ CDER Division of Anti-Inflammatory, Analgesic and Ophthalmologic Drug Products (DAAODP), Washington DC USA.Regulatory Affairs intern: Investigational New Drugs (IND),  New Drug Application (NDA),  End of phase II meeting,  Work on COX-II inhibitors